Non-Steroidal Anti-inflammatory Drugs Global Market Report 2026

Description

Non-steroidal anti-inflammatory drugs are medications that help decrease inflammation and reduce fever. They are commonly used to treat conditions such as headaches, sprains, strains, menstrual pain, colds and flu, arthritis, and various chronic pain issues. These drugs help alleviate inflammation, ease pain, and lower elevated body temperature.

The primary routes of administration include oral, topical, and other methods. Topical formulations are typically used to relieve muscle pain, sprains, and strains, as well as to alleviate the discomfort caused by arthritis. These drugs are indicated for conditions such as arthritis, migraines, ophthalmic diseases, and other medical conditions, and are available in hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs have created both challenges and opportunities for the non-steroidal anti-inflammatory drugs market by affecting the cost of raw materials, active pharmaceutical ingredients, and imported formulations. The resulting increase in production costs impacts oral and topical segments, particularly in regions like Asia-Pacific and Europe where imports are significant. Hospitals and retail pharmacies face higher procurement costs, while manufacturers are exploring local production and alternative sourcing strategies. Some positive effects include encouraging domestic manufacturing and boosting investment in local supply chains.

The non-steroidal anti-inflammatory drugs market research report is one of a series of new reports from The Business Research Company that provides non-steroidal anti-inflammatory drugs market statistics, including non-steroidal anti-inflammatory drugs industry global market size, regional shares, competitors with a non-steroidal anti-inflammatory drugs market share, detailed non-steroidal anti-inflammatory drugs market segments, market trends and opportunities, and any further data you may need to thrive in the non-steroidal anti-inflammatory drugs industry. This non-steroidal anti-inflammatory drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-steroidal anti-inflammatory drugs market size has grown strongly in recent years. It will grow from $21.89 billion in 2025 to $23.31 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing prevalence of arthritis and musculoskeletal disorders, rising awareness of pain management therapies, growth in geriatric population, expansion of retail pharmacies, advancements in drug formulation technologies.

The non-steroidal anti-inflammatory drugs market size is expected to see strong growth in the next few years. It will grow to $29.96 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to adoption of personalized medicine, growth of e-pharmacy platforms, increasing r&d in novel nsaid formulations, rising incidence of chronic inflammatory diseases, integration of digital health solutions for pain monitoring. Major trends in the forecast period include personalized pain management solutions, rising demand for otc anti-inflammatory drugs, development of rapid-acting formulations, focus on chronic pain and arthritis management, expansion of online pharmacy channels.

The growing prevalence of musculoskeletal disorders is expected to drive the expansion of the non-steroidal anti-inflammatory drug market in the coming years. Musculoskeletal disorders (MSDs) encompass a wide range of conditions that affect the musculoskeletal system, including muscles, bones, tendons, ligaments, joints, and other connective tissues. Non-steroidal anti-inflammatory drugs (NSAIDs) play a vital role in managing pain and inflammation associated with conditions such as arthritis, osteoarthritis, and rheumatoid arthritis. Contributing factors to this growth include the aging population, greater awareness and diagnosis of musculoskeletal disorders, orthopedic procedures, sports-related injuries, and the chronic nature of these conditions. For example, in January 2024, the UK-based government department GOV.UK reported that in 2023, 18.4% of individuals aged 16 and older reported having a long-term musculoskeletal (MSK) condition, an increase from the 17.6% prevalence recorded in 2022. As a result, the rising prevalence of musculoskeletal disorders is fueling the growth of the non-steroidal anti-inflammatory drugs market.

The increasing prevalence of chronic pain is anticipated to propel the growth of the non-steroidal anti-inflammatory drugs (NSAIDs) market and associated pain management solutions in the coming years. Chronic pain refers to persistent or recurrent pain that lasts for three months or more, often resulting from conditions such as arthritis, fibromyalgia, back pain, neuropathic pain, and other musculoskeletal disorders. These conditions have a profound impact on patients' quality of life and frequently require long-term management, which may include medication, physical therapy, and supportive care. As chronic pain becomes more prevalent, the demand for effective pain relief treatments, such as NSAIDs and other analgesic formulations, continues to rise. For example, in October 2024, the National Center for Biotechnology Information, a U.S.-based federal government research agency, reported that 24.3% of adults experienced chronic pain, with 8.5% suffering from high-impact chronic pain that limits daily activities. As a result, the growing number of individuals affected by chronic pain is expected to drive demand for pain management therapies, thereby supporting the expansion of the NSAIDs market and related products.

Leading companies in the non-steroidal anti-inflammatory drugs (NSAIDs) market are focusing on developing innovative solutions, such as combination analgesic-gastroprotective formulations, to address the growing demand for effective pain relief with reduced gastrointestinal risks typically associated with long-term NSAID use. These combination technologies pair an NSAID with a protective agent, allowing for the retention of anti-inflammatory efficacy while minimizing stomach irritation, offering a safer alternative to traditional single-agent NSAIDs. For example, in March 2024, Endo International plc, an Ireland-based pharmaceutical company, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets. This advanced formulation combines the analgesic and anti-inflammatory properties of ibuprofen with the gastroprotective benefits of famotidine. The dual-action tablet is designed to relieve pain while reducing gastrointestinal side effects like ulcers or irritation, which often arise with extended NSAID use, thereby enhancing safety and promoting better patient adherence.

Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company

North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the non-steroidal anti-inflammatory drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The non-steroidal anti-inflammatory drugs market consists of sales of high-dose aspirin, indomethacin, mefenamic acid, celecoxib, and other types. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Non-Steroidal Anti-inflammatory Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses non-steroidal anti-inflammatory drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for non-steroidal anti-inflammatory drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The non-steroidal anti-inflammatory drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Route Of Administration: Oral; Topical; Other Route Of Administration
2) By Disease Indication: Arthritis; Migraine; Ophthalmic Diseases; Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Oral: Tablets; Capsules; Liquids Or Solutions
2) By Topical: Gels; Creams; Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular); Suppositories
Companies Mentioned: Pfizer Inc.; Bayer AG; Johnson & Johnson; Sun Pharmaceutical Industries Ltd.; Assertio Therapeutics Inc.; Iroko Pharmaceuticals Inc.; Perrigo Company PLC; Hikma Pharmaceuticals PLC; Glenmark Pharmaceuticals Limited; Aspen Pharmacare Holdings Limited; Sagent Pharmaceuticals Inc.; Advanced Pharma Inc.; Akorn Operating Company LLC; Alembic Pharmaceuticals Limited; Torrent Pharmaceuticals Limited; Lupin Limited; Cipla Limited; Zydus Cadila Healthcare Limited; Aurobindo Pharma Limited; Sanofi S.A.; GlaxoSmithKline PLC; Horizon Therapeutics PLC; Novartis AG; Roche Holding AG; AbbVie Inc.; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH5MNSAI01_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Non-Steroidal Anti-inflammatory Drugs Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Non-Steroidal Anti-inflammatory Drugs Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Non-Steroidal Anti-inflammatory Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Non-Steroidal Anti-inflammatory Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Diitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
- 4.2.1 Personalized Pain Management Solutions
- 4.2.2 Rising Demand For Otc Anti-Inflammatory Drugs
- 4.2.3 Development Of Rapid-Acting Formulations
- 4.2.4 Focus On Chronic Pain And Arthritis Management
- 4.2.5 Expansion Of Online Pharmacy Channels

5. Non-Steroidal Anti-inflammatory Drugs Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Clinics
5.3 Retail Pharmacies
5.4 Online Pharmacies
5.5 Geriatric Care Centers

6. Non-Steroidal Anti-inflammatory Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Non-Steroidal Anti-inflammatory Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Non-Steroidal Anti-inflammatory Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Non-Steroidal Anti-inflammatory Drugs Market Size, Comparisons And Growth Rate Analysis
7.3. Global Non-Steroidal Anti-inflammatory Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Non-Steroidal Anti-inflammatory Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Non-Steroidal Anti-inflammatory Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Non-Steroidal Anti-inflammatory Drugs Market Segmentation

9.1. Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Topical, Other Route Of Administration
9.2. Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
9.3. Global Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
9.4. Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tablets, Capsules, Liquids Or Solutions
9.5. Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Topical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Gels, Creams, Patches
9.6. Global Non-Steroidal Anti-inflammatory Drugs Market, Sub-Segmentation Of Other Route Of Administration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injectable (Intravenous And Intramuscular), Suppositories

10. Non-Steroidal Anti-inflammatory Drugs Market Regional And Country Analysis

10.1. Global Non-Steroidal Anti-inflammatory Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Non-Steroidal Anti-inflammatory Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Non-Steroidal Anti-inflammatory Drugs Market

11.1. Asia-Pacific Non-Steroidal Anti-inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Non-Steroidal Anti-inflammatory Drugs Market

12.1. China Non-Steroidal Anti-inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Non-Steroidal Anti-inflammatory Drugs Market

13.1. India Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Non-Steroidal Anti-inflammatory Drugs Market

14.1. Japan Non-Steroidal Anti-inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Non-Steroidal Anti-inflammatory Drugs Market

15.1. Australia Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Non-Steroidal Anti-inflammatory Drugs Market

16.1. Indonesia Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Non-Steroidal Anti-inflammatory Drugs Market

17.1. South Korea Non-Steroidal Anti-inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Non-Steroidal Anti-inflammatory Drugs Market

18.1. Taiwan Non-Steroidal Anti-inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Non-Steroidal Anti-inflammatory Drugs Market

19.1. South East Asia Non-Steroidal Anti-inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Non-Steroidal Anti-inflammatory Drugs Market

20.1. Western Europe Non-Steroidal Anti-inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Non-Steroidal Anti-inflammatory Drugs Market

21.1. UK Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Non-Steroidal Anti-inflammatory Drugs Market

22.1. Germany Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Non-Steroidal Anti-inflammatory Drugs Market

23.1. France Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Non-Steroidal Anti-inflammatory Drugs Market

24.1. Italy Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Non-Steroidal Anti-inflammatory Drugs Market

25.1. Spain Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Non-Steroidal Anti-inflammatory Drugs Market

26.1. Eastern Europe Non-Steroidal Anti-inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Non-Steroidal Anti-inflammatory Drugs Market

27.1. Russia Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Non-Steroidal Anti-inflammatory Drugs Market

28.1. North America Non-Steroidal Anti-inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Non-Steroidal Anti-inflammatory Drugs Market

29.1. USA Non-Steroidal Anti-inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Non-Steroidal Anti-inflammatory Drugs Market

30.1. Canada Non-Steroidal Anti-inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Non-Steroidal Anti-inflammatory Drugs Market

31.1. South America Non-Steroidal Anti-inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Non-Steroidal Anti-inflammatory Drugs Market

32.1. Brazil Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Non-Steroidal Anti-inflammatory Drugs Market

33.1. Middle East Non-Steroidal Anti-inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Non-Steroidal Anti-inflammatory Drugs Market

34.1. Africa Non-Steroidal Anti-inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Non-Steroidal Anti-inflammatory Drugs Market, Segmentation By Route Of Administration, Segmentation By Disease Indication, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Non-Steroidal Anti-inflammatory Drugs Market Regulatory and Investment Landscape

36. Non-Steroidal Anti-inflammatory Drugs Market Competitive Landscape And Company Profiles

36.1. Non-Steroidal Anti-inflammatory Drugs Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Non-Steroidal Anti-inflammatory Drugs Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Non-Steroidal Anti-inflammatory Drugs Market Company Profiles
- 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Assertio Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Non-Steroidal Anti-inflammatory Drugs Market Other Major And Innovative Companies

Iroko Pharmaceuticals Inc., Perrigo Company PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A.

38. Global Non-Steroidal Anti-inflammatory Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Non-Steroidal Anti-inflammatory Drugs Market

40. Non-Steroidal Anti-inflammatory Drugs Market High Potential Countries, Segments and Strategies

40.1 Non-Steroidal Anti-inflammatory Drugs Market In 2030 - Countries Offering Most New Opportunities
40.2 Non-Steroidal Anti-inflammatory Drugs Market In 2030 - Segments Offering Most New Opportunities
40.3 Non-Steroidal Anti-inflammatory Drugs Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer